• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Stroke prevention in nonvalvular atrial fibrillation: update on target-specific oral anticoagulants.

作者信息

Patrick Carol, Clarke Randi

出版信息

J Contin Educ Nurs. 2015 Apr;46(4):152-4. doi: 10.3928/00220124-20150320-12.

DOI:10.3928/00220124-20150320-12
PMID:25856447
Abstract

Atrial fibrillation is the most common arrhythmia in adults, and the risk for stroke is increased five-fold. Efforts should be made to educate health care providers to understand the importance of using risk stratification tools. New oral anticoagulants are available for thromboembolic stroke prevention, and knowledge of their clinical indications and use is essential.

摘要

相似文献

1
Stroke prevention in nonvalvular atrial fibrillation: update on target-specific oral anticoagulants.
J Contin Educ Nurs. 2015 Apr;46(4):152-4. doi: 10.3928/00220124-20150320-12.
2
Benefits and risks of oral anticoagulation for stroke prevention in nonvalvular atrial fibrillation.非瓣膜性心房颤动患者口服抗凝药物预防卒中的获益与风险。
Thromb Res. 2012 Jan;129(1):9-16. doi: 10.1016/j.thromres.2011.09.023. Epub 2011 Oct 21.
3
[Antithrombotic therapy in patients with first-ever stroke and known non-rheumatic atrial fibrillation].[首次发生卒中且已知非风湿性心房颤动患者的抗栓治疗]
Praxis (Bern 1994). 2005 Jan 26;94(4):97-104. doi: 10.1024/0369-8394.94.4.97.
4
Warfarin for stroke prevention in hemodialysis patients with non-valvular atrial fibrillation.华法林用于非瓣膜性心房颤动血液透析患者的卒中预防。
CANNT J. 2015 Jul-Sep;25(3):22-5; quiz 26-7.
5
Oral Anticoagulants and Atrial Fibrillation: An Update for the Clinical Nurse.口服抗凝剂与心房颤动:临床护士最新资讯
Medsurg Nurs. 2015 Mar-Apr;24(2):95-100.
6
[Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?].[希美加群用于心房颤动的抗栓治疗:它能替代华法林吗?]
Anadolu Kardiyol Derg. 2007 Mar;7(1):54-8.
7
Do the current atrial fibrillation guidelines for stroke prevention need to be changed with the availability of new data on the new oral anticoagulants?鉴于新型口服抗凝剂的新数据已经可得,当前关于预防中风的心房颤动指南是否需要更改?
Int J Clin Pract. 2012 May;66(5):422-4. doi: 10.1111/j.1742-1241.2011.02815.x.
8
Comparative efficacy and safety of the non-vitamin K antagonist oral anticoagulants for patients with nonvalvular atrial fibrillation.非维生素K拮抗剂口服抗凝剂用于非瓣膜性心房颤动患者的疗效和安全性比较
Semin Thromb Hemost. 2015 Mar;41(2):146-53. doi: 10.1055/s-0035-1544156. Epub 2015 Feb 15.
9
A new era of oral anticoagulation in atrial fibrillation: implications in clinical practice.心房颤动口服抗凝治疗的新时代:对临床实践的影响
Hosp Pract (1995). 2013 Feb;41(1):61-70. doi: 10.3810/hp.2013.02.1011.
10
New anticoagulants (dabigatran, apixaban, rivaroxaban) for stroke prevention in atrial fibrillation.新型抗凝剂(达比加群、阿哌沙班、利伐沙班)用于预防房颤卒中。
Neurol Clin. 2013 Aug;31(3):659-75. doi: 10.1016/j.ncl.2013.03.001.